“Secret Plan for £22bn of NHS Cuts”

DC Surgical Supplies NHS Cuts Article Daily MirrorIn November 2015 the government set the NHS a target to achieve savings of £22 billion by 2020/21. Just a few years in and it is struggling to achieve that objective.

An area where costs could be reduced is the procurement of orthopaedic equipment. Every year the NHS spends £500 million to £1 billion a year on such devices with each trust spending between £3 million and £4 million per annum. This figure is growing year on year.

A close examination of the situation leaves no doubt that the NHS is paying more in this area than should be considered acceptable. Part of the problem is the fact that the orthopaedic equipment market is dominated and dependent on large players such as Depuy Synthes, Zimmer Biomet, Stryker, Medtronic and Smith & Nephew and they do not compete on price.

Read our Business Plan for more information: DC Surgical Supplies – June 2018

Capital at Risk (click to expand)

To help you understand the risks involved when investing in shares, mini-bonds and funds on Crowdcube, please read the following risk summary.  Please #investaware and diversify your investments.

The need for diversification when you invest

Diversification involves spreading your money across different types of investments with different risks to reduce your overall risk. However, it will not lessen all types of risk.  Diversification is an essential part of investing. Investors should only invest a proportion of their available investment funds via Crowdcube and should balance this with safer, more liquid investments.

Risks when investing in equity or funds

Investing in shares (also known as equity) on Crowdcube does not involve a regular return on your investment unlike mini-bonds which offer interest paid regularly.

Investing in a fund may help to diversify your investments and to spread the risk but general risks while investing in equity continues to apply. Further specific risks are set out on the applicable fund pitch page.

Register interest

Interested in investing? Submit your email address below and we will contact you shortly.*

*You will be sent a confirmation email – if you do not receive it, please check your junk/spam folder. Thank you.

Investor Information

  • Investors will subscribe for a package of ordinary shares.
  • The funding will be allocated to ordinary shares.
  • The share structure will be tailored to allow investors to recover their capital before any gains are distributed.
  • Management’s share of the profits will be via ordinary shares to align their interests with shareholders.


DC Surgical Supplies

EIS Approved

DC Surgical Supplies Ltd is a start-up company that will help NHS Trusts to make significant cost reductions by offering a new range of titanium maxiangle locking plates and compression screws that will be available at a price point which is 35% less than the NHS currently pays.

The company is able to bring this solution to the market having secured the license to be the sole and exclusive UK and Eire agent for the Palmer & Baker brand of orthopaedic internal fixation devices. DC Surgical Supplies will operate as a sales agency and a distribution company that will supply its products on a contractual basis. The initial renewable term of this agreement is five years.

DC Surgical Supplies’ key competitive edge is price. The pressure on NHS Acute Trusts to cut costs has never been greater. According to the King’s Fund, 44% of trusts were in deficit in 2016/17 with acute hospitals accounting for nearly 80% of that figure. As a lean and flexible start-up, DC Surgical Supplies is able to enter the market offering low prices for high quality and CE approved orthopaedic plates and screws. With a low priced option being available, Acute Trusts will find it difficult to justify spending more on orthopaedic devices than they have to, particularly those that are running with a deficit.